MSI2 and breast cancer: Initially, we used activation of a (transcription factor)/LEF-1-dependent luciferase reporter construct (TOPFLASH) in MCF7 (a luminal breast cancer cell line) to assess the effect of MSI2 overexpression on Wnt signalling.